-
1
KRAS pathway activity impacts GATA6 gene levels.
-
2
GATA6 is associated with pancreatic tumor differentiation.
-
3
Tumors with high GATA6 levels are generally less aggressive.
-
4
Blocking KRAS can restore GATA6 levels and sensitivity to chemotherapy.
-
5
Oxaliplatin is more effective in the presence of higher GATA
-
6
This research indicates new potential treatment strategies.
-
7
Understanding molecular switches can aid in diagnosis and treatment decisions.
Original Source(s)
Related Content
Building Quality into Advanced Therapies from Day One
Why early, risk-based thinking is critical in cell and gene therapy development
March 13, 2026
-
7 min
Engineering Safer Editors for Cystic Fibrosis Mutations
Modified APOBEC3G editors improve CRISPR base-editing specificity and reduce bystander mutations in human cells
March 13, 2026
-
2 min
Deep-UV Raman Reveals mRNA Encapsulation in Lipid Nanoparticles
Spectroscopic analysis reveals lipid–RNA interactions governing nanoparticle formulation efficiency
March 13, 2026
-
2 min
